Accent Microcell Ltd.

276.00 +4.45 ▲1.6%

01 March 2024, 03:40:05 PM
Volume: 78,000

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website https://accentmicrocell.com/
Market Cap 580.79 Cr.
Enterprise Value(EV) 586.64 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 6.18 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 44.64 Trailing Twelve Months Ending 2023-03
Industry PE 41.44 Trailing Twelve Months Ending 2023-03
Book Value / Share 64.20 Trailing Twelve Months Ending 2023-03
Price to Book Value 4.30 Calculated using Price: 276.00
Dividend Yield 0.29 Period Ending 2023-03
No. of Shares Subscribed 2.10 Cr. 21,043,000 Shares
FaceValue 10
About Accent Microcell Ltd.
The company is engaged in the manufacturing business of Pharmaceutical Excipients Range of Product.

Accent Microcell Ltd. Delivery

Delivered Qty
Traded Qty

Accent Microcell Ltd. Performance

1 Day
+1.64%
1 Week
+1.81%
1 Month
-9.31%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year

Accent Microcell Ltd. Fundamental Ratios

3 years 2021-03 2022-03 2023-03
Return on Equity (%) 18.04 20.07 34.11
Return on Capital Employed (%) 16.38 18.78 29.27
Return on Assets (%) 5.95 6.72 12.47

Accent Microcell Ltd. Balance Sheet

Particulars 4 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 27 32 44 76
Non Curr. Liab. 19 9 7 5
Curr. Liab. 35 54 63 31
Minority Int.
Equity & Liab. 81 95 114 112
Non Curr. Assets 31 31 32 32
Curr. Assets 50 64 82 80
Misc. Exp. not W/O
Total Assets 81 95 114 112

Accent Microcell Ltd. Profit and Loss

Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 133 166 204
Other Income 2 2 3
Total Income 135 168 207
Total Expenditure -122 -153 -185
PBIDT 13 15 22
Interest -3 -3 -3
Depreciation -4 -4 -4
Taxation -1 -2 -2
Exceptional Items
PAT 5 6 13
Adjusted EPS 4 2 10

Accent Microcell Ltd. Cash Flow

Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 5 15 8
Cash Fr. Inv. -6 -4 -4
Cash Fr. Finan. -2 -10 -4
Net Change -3 1 -1
Cash & Cash Eqvt 0 1 0

Accent Microcell Ltd. Shareholding Pattern

No shareholding pattern found.

Accent Microcell Ltd. Announcements

Tue, 27 Feb 2024
Outcome of Board Meeting
Accent Microcell Limited has informed the Exchange regarding Board meeting held on February 27, 2024.
Tue, 27 Feb 2024
Appointment
Accent Microcell Limited has informed the Exchange regarding Appointment of M/s. SUNIL MULCHANDANI & ASSOCIATES as the Secretarial Auditors of the Company for the F.Y. 2023-24 w.e.f. February 27, 2024.
Tue, 27 Feb 2024
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
ACCENT MICROCELL LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

Accent Microcell Ltd. Technical Scans

Fri, 01 Mar 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Accent Microcell Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 373,984.34 1,558.70 -1.1%
Cipla Ltd. 118,731.16 1,468.00 -0.8%
Dr. Reddy's Laboratories Ltd. 103,380.78 6,197.40 -3.5%
Zydus Lifesciences Ltd. 93,644.07 925.15 -1.8%
Divi's Laboratories Ltd. 92,353.86 3,485.00 -0.1%
Torrent Pharmaceuticals Ltd. 90,254.94 2,668.20 +0.1%
Apollo Hospitals Enterprise Ltd. 87,460.61 6,067.10 -0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.99 1,558.70 -1.1%
Cipla Ltd. Consolidated 2023-12 32.02 1,468.00 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.77 6,197.40 -3.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.49 925.15 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-12 66.78 3,485.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.41 2,668.20 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 110.81 6,067.10 -0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.99 1,558.70 -1.1%
Cipla Ltd. Consolidated 2023-12 4.59 1,468.00 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.85 6,197.40 -3.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.82 925.15 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-12 7.09 3,485.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.62 2,668.20 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.95 6,067.10 -0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,558.70 -1.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,468.00 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,197.40 -3.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 925.15 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,485.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,668.20 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,067.10 -0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,558.70 -1.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,468.00 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,197.40 -3.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.15 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,485.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,668.20 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,067.10 -0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,558.70 -1.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,468.00 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,197.40 -3.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.15 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,485.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,668.20 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,067.10 -0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,558.70 -1.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,468.00 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,197.40 -3.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 925.15 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,485.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,668.20 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,067.10 -0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,558.70 -1.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,468.00 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,197.40 -3.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 925.15 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,485.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,668.20 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,067.10 -0.6%

Accent Microcell Ltd. FAQ's

What is Accent Microcell share price?

Can I buy Accent Microcell shares now?

What is the Dividend Yield of Accent Microcell?

What is the Market Cap of Accent Microcell?

What are the key metrics to analyse Accent Microcell?

What is the 52 Week High and Low of Accent Microcell?

What is the trend of Accent Microcell share price?